Web-based training on clinical research
The purpose of the development initiative is to increase the understanding of the importance of clinical research and to improve the opportunities for recruiting patients for clinical studies. The goal is to develop a basic, web-based training on clinical research aimed at healthcare professionals who are not themselves active in research.
One of the regions' assignments, in addition to healthcare, is to conduct research and development. In order for healthcare to be able to conduct clinical research in the best possible way, everyone who works in healthcare needs an understanding of what clinical research is and its significance for healthcare, society, citizens and patients.
Initially, an inventory is made of existing educational material within Clinical Studies Sweden and a survey of other sources of information. Then a general plan is produced, and based on this, content is produced for an educational film that can be offered to bussinesses for use in, for example, introductory programs, APT, R&D days, development days, etc. Dissemination of educational material will take place nationally through the regional nodes within the collaboration Clinical Studies Sweden. A shorter version of the education aimed at the general public will also be produced.
The initiative will result in a web-based, comprehensive training to highlight the need and significance of clinical research. Through the dissemination of the education, the initiative is expected to contribute to improved conditions for conducting clinical studies and thereby enhance social benefit by:
- inspire increased commitment to clinical research among healthcare professionals
- improve the recruitment of patients for studies
- increase knowledge of clinical research and awareness of the opportunity to participate in clinical trials.
- increase understanding in health care that employees do research and that it is an important task for the business
The initiative started in Q1 2021 and is expected to be completed in Q4 2021.